Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
CHINA OILFIELD
02883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -10.95%8.47B | ---- | 2.72%9.51B | ---- | 12.82%9.26B | ---- | -68.85%8.2B | ---- | 170.62%26.34B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 27.45%-695M | ---- | -10.11%-958M | ---- | -1.28%-870M | ---- | -59.07%-859M | ---- | -46.34%-540M | ---- |
| Interest expense - adjustment | -19.05%650M | ---- | -16.35%803M | ---- | 6.79%960M | ---- | 5.64%899M | ---- | 3.15%851M | ---- |
| Attributable subsidiary (profit) loss | -9.86%-1.24B | ---- | -7.75%-1.13B | ---- | -5.34%-1.05B | ---- | 26.84%-992M | ---- | -159.27%-1.36B | ---- |
| Impairment and provisions: | 53.15%925M | ---- | 64.13%604M | ---- | -26.40%368M | ---- | 192.40%500M | ---- | --171M | ---- |
| -Impairment of property, plant and equipment (reversal) | 29.56%732M | ---- | 53.53%565M | ---- | -26.40%368M | ---- | 214.47%500M | ---- | --159M | ---- |
| -Other impairments and provisions | 394.87%193M | ---- | --39M | ---- | ---- | ---- | ---- | ---- | --12M | ---- |
| Asset sale loss (gain): | 84.67%-105M | ---- | -789.61%-685M | ---- | 1.28%-77M | ---- | 99.54%-78M | ---- | -67,948.00%-16.96B | ---- |
| -Loss (gain) from sale of subsidiary company | 89.79%-69M | ---- | -940.00%-676M | ---- | -1.56%-65M | ---- | 99.62%-64M | ---- | -188,544.44%-16.96B | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -300.00%-36M | ---- | 25.00%-9M | ---- | 14.29%-12M | ---- | -600.00%-14M | ---- | -112.50%-2M | ---- |
| Depreciation and amortization: | 2.19%5.27B | ---- | 3.37%5.16B | ---- | 2.15%4.99B | ---- | 5.71%4.89B | ---- | -33.61%4.62B | ---- |
| -Depreciation | 2.19%5.27B | ---- | 3.37%5.16B | ---- | 2.15%4.99B | ---- | 5.71%4.89B | ---- | -33.61%4.62B | ---- |
| Exchange Loss (gain) | -135.59%-21M | ---- | -57.86%59M | ---- | -76.23%140M | ---- | 331.89%589M | ---- | 59.10%-254M | ---- |
| Special items | 2.14%3.2B | ---- | -6.29%3.13B | ---- | 4.67%3.34B | ---- | -28.51%3.19B | ---- | 27.02%4.46B | ---- |
| Operating profit before the change of operating capital | -0.25%16.45B | ---- | -3.34%16.49B | ---- | 4.43%17.06B | ---- | -5.73%16.34B | ---- | -11.32%17.33B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 370.00%94M | ---- | 125.97%20M | ---- | -120.00%-77M | ---- | 88.71%-35M | ---- | -187.57%-310M | ---- |
| Accounts receivable (increase)decrease | -104.44%-1.2B | ---- | -164.07%-585M | ---- | 674.21%913M | ---- | -111.89%-159M | ---- | 217.90%1.34B | ---- |
| Accounts payable increase (decrease) | 197.51%391M | ---- | -154.78%-401M | ---- | -30.62%732M | ---- | 55.60%1.06B | ---- | -7.88%678M | ---- |
| prepayments (increase)decrease | -727.34%-872M | ---- | 115.71%139M | ---- | -316.38%-885M | ---- | 110.17%409M | ---- | -694.67%-4.02B | ---- |
| Special items for working capital changes | --371M | ---- | ---- | ---- | -110.99%-30M | ---- | 250.00%273M | ---- | 310.53%78M | ---- |
| Cash from business operations | -2.72%15.24B | -15.96%6.08B | -11.57%15.67B | -12.66%7.24B | -0.93%17.71B | 1.61%8.29B | 18.46%17.88B | 56.02%8.16B | -25.26%15.09B | -43.23%5.23B |
| Other taxs | 22.63%-2.44B | 10.03%-1.7B | 5.55%-3.15B | -0.27%-1.89B | -21.84%-3.34B | -13.39%-1.88B | 9.22%-2.74B | 14.67%-1.66B | 12.27%-3.02B | 8.22%-1.94B |
| Special items of business | ---371M | ---- | ---- | ---- | 110.99%30M | ---- | -250.00%-273M | ---- | -310.53%-78M | ---- |
| Net cash from operations | -0.67%12.43B | -18.05%4.39B | -13.15%12.51B | -16.45%5.35B | -3.11%14.41B | -1.40%6.41B | 23.92%14.87B | 97.84%6.5B | -28.31%12B | -53.69%3.28B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -3.49%802M | ---- | -6.52%831M | ---- | 13.39%889M | ---- | 45.19%784M | ---- | 54.29%540M | ---- |
| Dividend received - investment | 8.83%986M | ---- | -1.20%906M | ---- | 21.30%917M | ---- | 0.80%756M | ---- | 33.69%750M | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | -0.51%195M | ---- | -42.69%196M | ---- |
| Decrease in deposits (increase) | 305.77%3.94B | 393.49%3.87B | -19.44%970M | -62.95%784M | 106.19%1.2B | 112.43%2.12B | ---19.44B | ---17.02B | ---- | ---- |
| Sale of fixed assets | 85.19%450M | ---- | -70.44%243M | ---- | -42.40%822M | ---- | 4.54%1.43B | ---- | 238.71%1.37B | ---- |
| Sale of subsidiaries | -151.28%-40M | ---- | -12.36%78M | ---- | -97.88%89M | ---- | -87.13%4.2B | -87.52%4.05B | 32,847.47%32.62B | --32.47B |
| Acquisition of subsidiaries | -6,900.00%-70M | ---- | 80.00%-1M | ---- | 98.69%-5M | ---- | 20.79%-381M | ---- | 65.14%-481M | ---- |
| Cash on investment | 27.73%-305M | ---- | -539.39%-422M | ---- | 86.16%-66M | ---- | 82.62%-477M | ---- | -278.10%-2.75B | ---- |
| Other items in the investment business | 3.51%-5.88B | 51.06%-811M | -24.13%-6.1B | -67.04%-1.66B | 10.95%-4.91B | 41.92%-992M | 16.96%-5.52B | 38.76%-1.71B | 21.70%-6.64B | 31.10%-2.79B |
| Net cash from investment operations | 96.48%-123M | 450.29%3.06B | -229.03%-3.49B | -177.67%-873M | 94.25%-1.06B | 107.66%1.12B | -172.07%-18.45B | -149.45%-14.68B | 389.84%25.6B | 833.33%29.69B |
| Net cash before financing | 36.40%12.31B | 66.20%7.44B | -32.40%9.02B | -40.52%4.48B | 472.61%13.35B | 192.04%7.53B | -109.53%-3.58B | -124.81%-8.18B | 375.67%37.6B | 983.44%32.97B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 41.41%9.13B | 5.81%3.75B | 4.89%6.46B | 40.31%3.55B | -27.04%6.16B | -12.25%2.53B | 5.21%8.44B | -49.08%2.88B | -51.73%8.02B | -51.31%5.66B |
| Refund | -63.25%-11.73B | -109.97%-7.52B | -4.57%-7.18B | -11.83%-3.58B | 18.04%-6.87B | 3.23%-3.2B | 12.88%-8.38B | 45.83%-3.31B | 48.35%-9.62B | 45.24%-6.11B |
| Interest paid - financing | 1.30%-758M | ---- | 20.58%-768M | ---- | -4.09%-967M | ---- | 10.24%-929M | ---- | 28.91%-1.04B | ---- |
| Dividends paid - financing | 19.90%-5.68B | 10.27%-1.76B | -59.28%-7.1B | -43.82%-1.97B | -20.28%-4.46B | -58.77%-1.37B | 84.69%-3.7B | -20.76%-861M | -273.33%-24.19B | -35.04%-713M |
| Absorb investment income | 25.14%667M | ---- | -17.36%533M | ---- | 1,742.86%645M | ---- | -97.57%35M | ---- | 132.42%1.44B | ---- |
| Other items of the financing business | ---- | 21.07%-311M | 58.00%-42M | 51.30%-394M | -488.24%-100M | -13.78%-809M | 45.16%-17M | -615.22%-711M | -55.00%-31M | 115.16%138M |
| Net cash from financing operations | -3.67%-8.9B | -143.97%-5.84B | -42.18%-8.59B | 15.99%-2.4B | -22.74%-6.04B | -42.48%-2.85B | 80.87%-4.92B | -94.84%-2B | -162.27%-25.72B | -5.33%-1.03B |
| Effect of rate | 27.03%47M | 440.00%51M | 1,133.33%37M | 6.25%-15M | -94.00%3M | -900.00%-16M | 166.67%50M | 102.74%2M | -59.57%-75M | -630.00%-73M |
| Net Cash | 679.41%3.41B | -23.18%1.6B | -94.02%437M | -55.46%2.08B | 185.96%7.31B | 145.95%4.68B | -171.57%-8.5B | -131.88%-10.18B | 724.22%11.88B | 1,444.58%31.94B |
| Begining period cash | 1.73%27.83B | 1.73%27.83B | 36.48%27.35B | 36.48%27.35B | -29.66%20.04B | -29.66%20.04B | 70.72%28.49B | 70.72%28.49B | -10.46%16.69B | -10.46%16.69B |
| Cash at the end | 12.41%31.28B | 0.19%29.48B | 1.73%27.83B | 19.09%29.42B | 36.48%27.35B | 34.90%24.71B | -29.66%20.04B | -62.29%18.31B | 70.72%28.49B | 134.61%48.56B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | PwC | -- | PwC | -- | PwC | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.